MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-DL-08-0045222
Prax Impex Private Limited
Prax Impex Private Limited - pharma in Delhi, India. Directors, charges & compliance details.
Revenue · FY 2025
₹14.53 Cr
▲ 130% YoY
Net profit · FY 2025
₹59.83 Lakh
Net margin 4.1%
EBITDA · FY 2025
₹1.07 Cr
EBITDA margin 7.4%
Authorised capital
₹80 Lakh
Registered with MCA
Paid-up capital
₹1.17 Lakh
Issued & subscribed
Open charges
₹22.9 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
About Prax Impex Private Limited
Data last updated:
Prax Impex Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85300DL2021PTC388846.
The company has an authorised share capital of ₹80 Lakh and a paid-up capital of ₹1.17 Lakh. It is led by directors Munchun Kumar and Abhishek Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S – 24 Second Floor (S/F) Back Portion (B/P) Greater Kailash II, Delhi, India – 110048.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.53 Cr, a growth of 130% compared to the previous year. For the same year it recorded a net profit of ₹59.83 Lakh (net margin 4.1%) and EBITDA of ₹1.07 Cr (EBITDA margin 7.4%). Revenue has grown at a compounded annual rate (CAGR) of 173% over three years.
As per MCA filings, the company has open charges of ₹22.9 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Prax Impex Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-DL-08-0045222). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U85300DL2021PTC388846
Registration Number 388846
Incorporation Date 25 October 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-DL-08-0045222
Key People
Munchun Kumar Director Abhishek Gupta Director Recognitions & Rankings of Prax Impex
Contact details
Prax Impex Private Limited's registered office is in Delhi, Delhi.
- Registered AddressS – 24 Second Floor (S/F) Back Portion (B/P) Greater Kailash II, Delhi, India – 110048
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Prax Impex Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Prax Impex is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Prax Impex Private Limited, buy the company report.
Financials of Prax Impex Private Limited
FY 2025 filings availablePrax Impex Private Limited reported revenue of ₹14.53 Cr (up 130% YoY) for FY 2025.
Revenue · FY 2025
₹14.53 Cr ▲ 130%
Net profit · FY 2025
₹59.83 Lakh margin 4.1%
EBITDA · FY 2025
₹1.07 Cr margin 7.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 130%
3 years · compounded
▲ 173%
EBITDA CAGR growth
1 year
▲ 67%
3 years · compounded
▲ 359%
Revenue has grown at a compounded annual rate (CAGR) of 173% over three years, including 130% growth in the latest year. EBITDA rose 67% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.07 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹59.83 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 7.4% | |||
| Net Profit Margin | 4.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Prax Impex Private Limited, buy the company report.
Board of directors of Prax Impex Private Limited
Prax Impex has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Munchun Kumar | Director | 25 Oct 2021 | 5 Years 0 Months | Current |
| Abhishek Gupta Also directs: Rajnandani Projects Private Limited | Director | 06 Sep 2025 | 1 Years 1 Months | Current |
Charges & borrowings
Open charges
₹22.9 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jun 2025 | 101128084 | Others | ₹20 Cr | Open | |
| 04 Feb 2023 | 100682537 | Others | ₹2.9 Cr | Open |
Total charge records: 2 View all charges
Legal cases
Prax Impex Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gautam Buddha Nagar, Uttar Pradesh | Criminal case | Filed against the company by State of U.P. | Pending |
To see the full case history of Prax Impex Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Prax Impex Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Prax Impex Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Prax Impex Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Rajnandini ceased to be Director on 08 Sep 2025.
AGM
Prax Impex Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Rajnandini ceased to be Director.
Appointed
Abhishek Gupta was appointed as Director.
Charges
A charge with Others amounted to Rs. 2,000.00 Lakh with Charge ID 101128084 was registered on 30 Jun 2025.
Filing
Prax Impex Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Charges
A charge with Others amounted to Rs. 290.00 Lakh with Charge ID 100682537 was registered on 04 Feb 2023.
Ceased
Abhishek Rai ceased to be Director.
Appointed
Munchun Kumar was appointed as Director.
Incorporation
25 Oct 2021
Prax Impex Private Limited was registered on 25 Oct 2021 with Roc Delhi I & aged 5 years 1 day as per MCA records.
Frequently asked questions
Prax Impex is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 October 2021 (5+ years old) and is registered under CIN U85300DL2021PTC388846.
Prax Impex has 2 current directors:
- Munchun Kumar - Director
- Abhishek Gupta - Director
The latest financial statements of Prax Impex on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Prax Impex is U85300DL2021PTC388846. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prax Impex has 1 court case on record: 1 filed against it. 1 is pending.
Prax Impex was incorporated on 25 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Rajnandini ceased to be Director on 08 Sep 2025. Abhishek Gupta was appointed as Director on 06 Sep 2025. Abhishek Rai ceased to be Director on 31 Aug 2022. Prax Impex has 4 board changes on record in total.
Yes, Prax Impex is registered as an MSME under Udyam registration (number: UDYAM-DL-08-0045222).
The registered office of Prax Impex is at S – 24 Second Floor SF Back Portion BP Greater Kailash II, Delhi, India – 110048.
Prax Impex operates in the pharma industry, in the pharmaceutical retailers and distributors segment.